Versant Capital Management’s Immix Biopharma IMMX Stock Holding History

Versant Capital Management’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.49K	Buy	+335	New	+$3.79K	﹤0.01%	2518

Other funds holding IMMX

Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 15.9% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Aspect Partners Fairfax, Virginia $264M AUM 15.76% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Versant Capital Management's IMMX Position: Q3 2026 in Review

Versant Capital Management opened a new position in Immix Biopharma (IMMX) in Q3 2026: 335 shares worth $3.49K. The stake represents ﹤0.01% of the portfolio and ranks #2518 among its holdings.

11 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

Versant Capital Management held 335 shares of Immix Biopharma worth $3.49K as of Q3 2026.
Immix Biopharma was a new Versant Capital Management position in Q3 2026.
Immix Biopharma made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2518 holding.
11 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.